Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine

CONCLUSIONS: In this real-world study, fremanezumab demonstrated effectiveness for migraine regardless of migraine type or the presence of factors contributing to DTT migraine (MO, GAD, MDD, or prior exposure to a different CGRP mAb).PMID:35578182 | DOI:10.1186/s10194-022-01415-x

Source: Pain Physician - May 16, 2022 Category: Anesthesiology Authors: Maurice T Driessen Joshua M Cohen Stephen F Thompson Oscar Patterson-Lomba Michael J Seminerio Karen Carr Todor I Totev Rochelle Sun Erica Yim Fan Mu Rajeev Ayyagari Source Type: research